Analysts Viewpoint
SAVA Stock Sees Decline of Approximately -0.49% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Cassava Sciences Inc revealed its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Cassava Sciences, Inc. (SAVA) has seen a push of 7.26% in the aftermarket because the company announced that petition filed
The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a